Our core values guide everything we do, including the standards we use to ensure the quality and trustworthiness of our content and editorial processes
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (Duration-6): a randomised, open-label study
Not refrigerating : Reconstituted peptide degrades at room temperature
Side Effects However, there were some unpleasant side effects, as with any new drug
The useful move is to pick those patients up with simple noninvasive tests, rather than waiting on a separate liver workup to confirm an eligibility that, for most of them, is already there
otherwise, follow standard monitoring per diabetes and CKD care guidelines